Peter Bisgaard
Chairman at Engrail Therapeutics, Inc.
Profile
Peter Tuxen Bisgaard is currently the Chairman at Oncxerna Therapeutics, Inc. and Engrail Therapeutics, Inc. He is also the Managing Director at Novo Ventures 1 A, the Director at The Outpost Ltd., and the Managing Director at Nan Fung Life Sciences.
Additionally, he is the Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC since 2017.
In his former positions, Mr. Bisgaard served as the Chairman at HTG Molecular Diagnostics, Inc. from 2015 to 2017.
He was also the Chairman at Neurokey A and Otonomy, Inc. from 2013 to 2015.
Furthermore, he held the role of Independent Director at Ra Pharmaceuticals, Inc. from 2015 to 2019.
He has also served as an Independent Non-Executive Director at Eargo, Inc. from 2017 to 2022.
Additionally, he held various director positions at Light Sciences Oncology, Inc., Asante Solutions, Inc., Thesan Pharmaceuticals, Inc., Azanta Danmark A, Lundbeck Seattle BioPharmaceuticals, Inc., Nevro Corp., Hemofocus ApS, Altheos, Inc., Ceterix Orthopaedics, Inc., Bolt Biotherapeutics, Inc., Entasis Therapeutics, Inc., Chromaderm, Inc., Outpost Medicine, Inc., and Inozyme Pharma, Inc. He was also a Principal at McKinsey & Co., Inc. and a Senior Partner at Novo Holdings AS (Denmark) from 2009 to 2017.
Mr. Bisgaard obtained his graduate degree from the Technical University of Denmark in 1998.
Peter Bisgaard active positions
Companies | Position | Start |
---|---|---|
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Private Equity Investor | 2001-03-31 |
The Outpost Ltd. | Director/Board Member | - |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Private Equity Investor | 2017-08-31 |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Chairman | - |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Chairman | - |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Private Equity Investor | - |
Former positions of Peter Bisgaard
Companies | Position | End |
---|---|---|
EARGO, INC. | Director/Board Member | 2022-08-02 |
RA PHARMACEUTICALS, INC. | Director/Board Member | 2019-06-10 |
HTG MOLECULAR DIAGNOSTICS, INC. | Chairman | 2017-03-06 |
░░░░ ░░░░░░░░ ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Peter Bisgaard
Technical University of Denmark | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
NEVRO CORP. | Health Technology |
BOLT BIOTHERAPEUTICS, INC. | Health Technology |
EARGO, INC. | Health Technology |
INOZYME PHARMA, INC. | Health Technology |
Private companies | 22 |
---|---|
Light Sciences Oncology, Inc.
Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Light Sciences Oncology, Inc. operates as a pharmaceutical company. It develops Aptocine for the treatment of solid tumors as well as other indications such as benign prostatic hyperplasia. The company was founded in 1994 and is headquartered in Bellevue, WA. | Health Technology |
Asante Solutions, Inc.
Asante Solutions, Inc. Medical SpecialtiesHealth Technology Asante Solutions, Inc. operated as a medical device company that focuses on the management of diabetes for patients and healthcare practitioners. The firm offered Asante Snap insulin pump system (Snap system), a pump for individuals starting insulin pump therapy and for existing pumpers. The company was founded by James L. Peterson in 2006 and was headquartered in Sunnyvale, CA. | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Thesan Pharmaceuticals, Inc.
Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous |
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Finance |
Neurokey A/S
Neurokey A/S Pharmaceuticals: MajorHealth Technology Neurokey wants to become a leading drug development company in the critical care field. The drugs under development will one day help countless patients suffering from the effects of debilitating and potentially fatal cardiovascular and neurological; diseases. Neurokey will be first to market with reliable efficient and easily administered medication that will increase the survival rate for these patients and dramatically minimize the risk of permanent neurological damage. | Health Technology |
Hemofocus ApS
Hemofocus ApS Medical SpecialtiesHealth Technology Hemofocus ApS provides anticoagulant products. It develops pharmacological inventions that help to decrease bleeding during blood transfusions. The company was founded in 2008 and is headquartered in Bagsvaerd, Denmark. | Health Technology |
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
Altheos, Inc.
Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Health Technology |
Ceterix Orthopaedics, Inc.
Ceterix Orthopaedics, Inc. Medical SpecialtiesHealth Technology Ceterix Orthopaedics, Inc. develops novel surgical tools for arthroscopic procedures. It offers NovoStitch Pro Meniscal Repair System, a device designed to address complex meniscal tear patterns not adequately served by other repair systems. The company was founded by Justin Saliman and John G. McCutcheon in October 2010 and is headquartered in Fremont, CA. | Health Technology |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Chromaderm, Inc.
Chromaderm, Inc. BiotechnologyHealth Technology Chromaderm, Inc. operates as a clinical stage biotech company. It develops topical PKC-beta inhibitor. The company was founded by Barbara A. Gilchrest, Mark de Souza and James W. Fordyce and is headquartered in Cambridge, MA. | Health Technology |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA. | Health Technology |
The Outpost Ltd. | |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Finance |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong. | Finance |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Peter Bisgaard